HCP
AVNS

Hexagon Capital Partners’s Avanos Medical AVNS Stock Holding History

Hexagon Capital Partners’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-151
Closed -$4.49K – 1431
2023
Q1 		$4.49K Buy
+151
New +$4.38K ﹤0.01% 904

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Hexagon Capital Partners's AVNS Position: Q2 2023 in Review

Hexagon Capital Partners sold out of Avanos Medical (AVNS) in Q2 2023, closing a stake of 151 shares — an estimated $4.49K sold.

Hexagon Capital Partners first reported a position in AVNS in Q1 2023 and held it in 1 quarter. The position peaked at $4.49K in Q1 2023. 274 funds tracked by Wall St. Rank hold AVNS as of Q2 2023.

  • Hexagon Capital Partners reported no remaining Avanos Medical position as of Q2 2023 after selling out during the quarter.
  • Hexagon Capital Partners sold 151 Avanos Medical shares in Q2 2023, an estimated $4.49K.
  • Hexagon Capital Partners first reported a position in Avanos Medical in Q1 2023 and held it in 1 quarter.
  • Hexagon Capital Partners's Avanos Medical position peaked at $4.49K in Q1 2023.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2023.

Based on Hexagon Capital Partners's 13F filing for Q2 2023, filed 24 Jul 2023.